Serotonin and the heart

WH Frishman, P Grewall - Annals of medicine, 2000 - Taylor & Francis
Serotonin is a naturally occurring vasoactive substance that has diverse cardio-
physiological effects. These effects can be explained by the existence of serotonin receptor …

[HTML][HTML] Serotonin: a platelet hormone modulating cardiovascular disease

M Rieder, N Gauchel, C Bode… - Journal of thrombosis and …, 2021 - Springer
Cardiovascular diseases and depression are significant health burdens and increasing
evidence suggests a causal relationship between them. The incidence of depression among …

Serotonin and serotonin antagonism in cardiovascular and non‐cardiovascular disease

WH Frishman, S Huberfeld, S Okin… - The Journal of …, 1995 - Wiley Online Library
Serotonin, or 5‐hydroxytryptamine, is a naturally‐occurring vasoactive substance found
primarily in the brain, enterochromaffin tissue, and blood platelets. It has diffuse …

5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats

SW Watts, GD Fink - American Journal of Physiology-Heart …, 1999 - journals.physiology.org
We previously demonstrated a change in the receptors mediating 5-hydroxytryptamine (5-
HT)-induced contraction in arteries of deoxycorticosterone acetate (DOCA)-salt-hypertensive …

5-Hydroxytryptamine2B Receptor Function Is Enhanced in the N ω-Nitro-l-arginine Hypertensive Rat

A Russell, A Banes, H Berlin, GD Fink… - Journal of Pharmacology …, 2002 - ASPET
Arterial hyperresponsiveness to serotonin (5-hydroxytryptamine, 5-HT) is observed in
experimental models and human forms of hypertension. Presently, we test the hypothesis …

Serotonin-induced contraction in mesenteric resistance arteries: Signaling and changes in deoxycorticosterone acetate–salt hypertension

SW Watts - Hypertension, 2002 - Am Heart Assoc
Large arteries from hypertensive subjects are hyperresponsiveness to 5-hydroxytryptamine
(5-HT). We tested the hypothesis that small arteries (225 μ ID) have a profile similar to …

Beneficial hemodynamic effects of ketanserin in patients with cirrhosis: possible role of serotonergic mechanisms in portal hypertension

A Hadengue, SS Lee, R Moreau, A Braillon… - Hepatology, 1987 - journals.lww.com
We studied the acute effects of ketanserin, a serotonin S 2 antagonist, on systemic and
splanchnic hemodynamics in 11 patients with cirrhosis. Mean arterial pressure decreased …

5-Hydroxytryptamine mediates endothelium dependent coronary vasodilatation in the isolated rat heart by the release of nitric oxide

PS Mankad, AH Chester, MH Yacoub - Cardiovascular research, 1991 - academic.oup.com
Study objective–The aim was to investigate further the endothelium dependent vasodilator
action of 5-hydroxytryptamine (5-HT) on the rat coronary circulation. Design–Using saponin …

A most unusual acute coronary syndrome

C Bourgault, S Bergeron, P Bogaty, P Poirier - Canadian Journal of …, 2006 - Elsevier
A 60-year-old man, known for stable coronary artery disease, was admitted for suspected
unstable angina. In the previous month, the patient presented with progressive dyspnea on …

A new signaling paradigm for serotonin: use of Crk-associated substrate in arterial contraction

K Ogden, JM Thompson, Z Hickner… - American Journal …, 2006 - journals.physiology.org
Crk-associated substrate (CAS), a 130-kDa adaptor protein, was discovered as a tyrosine
kinase substrate of Src that was important to cellular motility and actin filament formation. As …